 | Up a level |
Scolari, Francesco; Delbarba, Elisa; Domenico, Santoro; Gesualdo, Loreto; Pani, Antonello; Dallera, Nadia; Mani, Laila-Yasmin; Santostefano, Marisa; Feriozzi, Sandro; Quaglia, Marco; Boscutti, Giuliano; Ferrantelli, Angelo; Marcantoni, Carmelita; Passerini, Patrizia; Magistroni, Riccardo; Alberici, Federico; Ghiggeri, Gian Marco; Ponticelli, Claudio; Ravani, Pietro (2021). Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial. Journal of the American Society of Nephrology : JASN, 32(4), pp. 972-982. American Society of Nephrology 10.1681/ASN.2020071091
Scolari, Francesco; Dallera, Nadia; Gesualdo, Loreto; Santoro, Domenico; Pani, Antonello; Santostefano, Marisa; Feriozzi, Sandro; Mani, Laila-Yasmin; Boscutti, Giuliano; Messa, Piergiorgio; Magistroni, Riccardo; Quaglia, Marco; Ponticelli, Claudio; Ravani, Pietro (2019). Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: protocol of a pilot randomised controlled trial. BMJ open, 9(12), e029232. BMJ Publishing Group 10.1136/bmjopen-2019-029232
Bettinelli, Alberto; Borsa, Nicolò; Bellantuono, Rosa; Syrèn, Marie-Louise; Calabrese, Raffaele; Edefonti, Alberto; Komninos, John; Santostefano, Marisa; Beccaria, Luciano; Pela, Ivana; Bianchetti, Mario G; Tedeschi, Silvana (2007). Patients with biallelic mutations in the chloride channel gene CLCNKB: long-term management and outcome. American Journal of Kidney Diseases, 49(1), pp. 91-8. Philadelphia, Pa.: W.B. Saunders 10.1053/j.ajkd.2006.10.001
